AJP - GI Information on EB 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 293: G919-G922, 2007. First published June 28, 2007; doi:10.1152/ajpgi.00242.2007
0193-1857/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/G919    most recent
00242.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wu, L.
Right arrow Articles by Kaer, L. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wu, L.
Right arrow Articles by Kaer, L. V.

THEMES

Role of NKT Cells in the Digestive System. II. NKT cells and diabetes

Lan Wu and Luc Van Kaer

Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee

Submitted 30 May 2007 ; accepted in final form 27 June 2007

Natural killer T (NKT) cells are a subset of regulatory T lymphocytes that recognize glycolipid antigens presented by the major histocompatibility complex class I-related glycoprotein CD1d. NKT cells have been implicated in regulating the progression of Type 1 diabetes (T1D) in human patients and in an animal model for T1D. In addition, glycolipid agonists of NKT cells have been successful in preventing diabetes in mice, raising enthusiasm for the development of NKT cell-based therapies for T1D.

{alpha}-galactosylceramide; CD1d; glycolipids; immunomodulation; immunotherapy; natural killer T cells; regulatory T cells; Type 1 diabetes



Address for reprint requests and other correspondence: L. Van Kaer, Dept. of Microbiology and Immunology, Vanderbilt Univ. School of Medicine, Medical Center North, Rm. A-5301, Nashville, TN 37232 (e-mail: luc.van.kaer{at}vanderbilt.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.